These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 27188791)
1. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor. Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791 [TBL] [Abstract][Full Text] [Related]
2. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation. Kim KM; Gainetdinov RR; Laporte SA; Caron MG; Barak LS J Biol Chem; 2005 Apr; 280(13):12774-80. PubMed ID: 15687500 [TBL] [Abstract][Full Text] [Related]
3. β-Arrestin2 directly or through GRK2 inhibits PKCβII activation in a ubiquitination-dependent manner. Zhang X; Zheng M; Sun N; Kim KM Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):142-157. PubMed ID: 29054428 [TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases. Liu H; Ma H; Zeng X; Wu C; Acharya S; Sudan SK; Zhang X Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373182 [TBL] [Abstract][Full Text] [Related]
6. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation. Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132 [TBL] [Abstract][Full Text] [Related]
7. Novel roles for β-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors. Min C; Zheng M; Zhang X; Caron MG; Kim KM Br J Pharmacol; 2013 Nov; 170(5):1112-29. PubMed ID: 23992580 [TBL] [Abstract][Full Text] [Related]
8. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor. Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346 [TBL] [Abstract][Full Text] [Related]
9. A novel molecular mechanism responsible for phosphorylation-independent desensitization of G protein-coupled receptors exemplified by the dopamine D Zheng M; Zhang X; Sun N; Min X; Acharya S; Kim KM Biochem Biophys Res Commun; 2020 Jul; 528(3):432-439. PubMed ID: 32505358 [TBL] [Abstract][Full Text] [Related]
10. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer. Guitart X; Navarro G; Moreno E; Yano H; Cai NS; Sánchez-Soto M; Kumar-Barodia S; Naidu YT; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Ferré S Mol Pharmacol; 2014 Oct; 86(4):417-29. PubMed ID: 25097189 [TBL] [Abstract][Full Text] [Related]
11. Agonist-induced changes in RalA activities allows the prediction of the endocytosis of G protein-coupled receptors. Zheng M; Zhang X; Guo S; Zhang X; Min C; Cheon SH; Oak MH; Kim YR; Kim KM Biochim Biophys Acta; 2016 Jan; 1863(1):77-90. PubMed ID: 26477566 [TBL] [Abstract][Full Text] [Related]
12. Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors. Zhang X; Le HT; Zhang X; Zheng M; Choi BG; Kim KM Biochim Biophys Acta; 2016 Sep; 1858(9):2152-2162. PubMed ID: 27349735 [TBL] [Abstract][Full Text] [Related]
13. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons. Bono F; Savoia P; Guglielmi A; Gennarelli M; Piovani G; Sigala S; Leo D; Espinoza S; Gainetdinov RR; Devoto P; Spano P; Missale C; Fiorentini C Mol Neurobiol; 2018 Feb; 55(2):1054-1067. PubMed ID: 28092083 [TBL] [Abstract][Full Text] [Related]
14. RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells. Luessen DJ; Hinshaw TP; Sun H; Howlett AC; Marrs G; McCool BA; Chen R Neuropharmacology; 2016 Nov; 110(Pt A):297-307. PubMed ID: 27528587 [TBL] [Abstract][Full Text] [Related]
15. Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. Adhikari P; Xie B; Semeano A; Bonifazi A; Battiti FO; Newman AH; Yano H; Shi L Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924613 [TBL] [Abstract][Full Text] [Related]
16. The EGF receptor inhibits the signaling of dopamine D Sun N; Zhang X; Zhang X; Kim KM Biochem Biophys Res Commun; 2017 Aug; 489(4):515-522. PubMed ID: 28579429 [TBL] [Abstract][Full Text] [Related]
17. Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D Kim KM Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047716 [TBL] [Abstract][Full Text] [Related]
18. GRK2-mediated receptor phosphorylation and Mdm2-mediated β-arrestin2 ubiquitination drive clathrin-mediated endocytosis of G protein-coupled receptors. Zhang X; Zheng M; Kim KM Biochem Biophys Res Commun; 2020 Dec; 533(3):383-390. PubMed ID: 32962859 [TBL] [Abstract][Full Text] [Related]
19. Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D Battiti FO; Zaidi SA; Katritch V; Newman AH; Bonifazi A J Med Chem; 2021 Nov; 64(21):16088-16105. PubMed ID: 34699207 [TBL] [Abstract][Full Text] [Related]
20. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum. Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]